Subscribe to our Newsletters !!
Like never seen before, coral reefs across the
Lab vials are some of the smallest containers in a
Dr. Mohammed Enayat’s recent testimony on his ag
It is with utmost pride that Microbioz India annou
The world of pharmaceuticals encompasses a broad s
Since it’s an ingredient in so many foods, you h
In our cover story, we shine a spotlight on “ The Magazine
Dr Reddy’s Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India.
Dr Reddy’s stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19.
“The need for high efficacy and quality, affordability and improved disease control are essential priorities for us. We think that Avigan would offer an effective treatment alternative to the COVID-19 affected sufferers in India,” M Ramana, CEO, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories, stated.
